Trainee | Trainer | |||||
---|---|---|---|---|---|---|
Number of participants that clicked on the cue | Place of the cue | Number of participants that clicked on the cue | Place of the cue | |||
n (%) | Range | Median (IQR) | n (%) | Range | Median (IQR) | |
History | ||||||
Orthopnoea | 107 (82.3) | 1–19 | 2 (2–3) | 46 (73.0)** | 1–6 | 2 (2–3) |
History of oedema | 106 (81.5) | 1–24 | 5 (3–9) | 43 (68.3) | 1–10 | 6 (4–9) |
Dyspnoea at rest | 88 (67.7) | 1–13 | 2 (1–3) | 47 (74.6) | 1–21 | 2 (1–2) |
Fatigue | 73 (56.2) | 1–14 | 6 (5–8) | 41 (65.1) | 1–16 | 6 (5–8) |
Dyspnoea on exertion | 69 (53.1) | 1–20 | 3 (2–4) | 44 (69.8) | 1–22 | 3 (2–4) |
Coughing | 67 (51.5) | 1–24 | 5 (4–6) | 44 (69.8) | 1–9 | 4 (3–5) |
Retrosternal pain | 63 (48.5) | 2–23 | 6 (5–7) | 35 (55.6) | 2–8 | 5 (4–7) |
Nocturnal paroxysmal dyspnoea | 54 (41.5) | 2–27 | 9 (6–14) | 32 (50.8) | 4–14 | 10 (7–14) |
Palpitations | 39 (30.0) | 2–26 | 9 (7–13) | 26 (41.3) | 4–13 | 10 (6–13) |
Fever | 35 (26.9) | 2–22 | 6 (5–7) | 21 (33.3) | 3–21 | 6 (5–6) |
Syncope | 29 (22.3) | 6–14 | 11 (10–12) | 12 (19.0) | 6–11 | 11 (10–11) |
Appetite | 28 (21.5) | 1–10 | 1 (1–1) | 18 (28.6) | 1–7 | 1 (1–1) |
Weight loss | 25 (19.2) | 1–25 | 10 (7–12) | 35 (55.6)* | 1–19 | 8 (6–12) |
Vertigo | 20 (15.4) | 1–28 | 9 (9–11) | 14 (22.2) | 4–23 | 9 (8–9) |
Clinical examination | ||||||
Lung auscultation | 105 (80.8) | 1–26 | 9 (6–13) | 49 (77.8) | 2–16 | 9 (7–13) |
Heart auscultation | 98 (75.4) | 1–27 | 9 (6–13) | 44 (69.8) | 1–15 | 10 (7–14) |
Clinical oedema | 88 (67.7) | 1–24 | 12 (8–18) | 45 (71.4) | 1–20 | 12 (8–17) |
Peripheral vessels | 73 (56.2) | 2–26 | 14 (9–21) | 27 (42.9)** | 2–23 | 16 (13–21) |
Jugular venous pressure | 71 (54.6) | 1–25 | 12 (8–17) | 37 (58.7) | 1–28 | 12 (9–17) |
Parameters (e.g., pulse) | 67 (51.5) | 3–21 | 12 (9–18) | 28 (44.4) | 6–18 | 13 (11–18) |
Weight | 65 (50.0) | 1–30 | 15 (10–22) | 37 (58.7) | 3–23 | 15 (12–21) |
Respiratory rate and saturation | 63 (48.5) | 3–25 | 15 (11–20) | 35 (55.6) | 5–21 | 15 (11–19) |
Abdominal examination | 40 (30.8) | 1–30 | 21 (15–24) | 27 (42.9)** | 4–25 | 19 (15–23) |
Apex beat | 35 (26.9) | 7–31 | 24 (15–25) | 22 (34.9) | 2–26 | 19 (14–24) |
Neurological examination | 29 (22.3) | 8–32 | 25 (17–26) | 18 (28.6) | 7–27 | 23 (17–25) |
Technical investigation | ||||||
Chest X-ray | 71 (54.6) | 2–42 | 16 (11–25) | 44 (69.8)* | 1–32 | 16 (11–25) |
NT-proBNP | 71 (54.6) | 2–38 | 15 (9–24) | 35 (55.6) | 1–29 | 19 (14–25) |
Electrocardiography | 58 (44.6) | 5–35 | 19 (12–26) | 35 (55.6) | 6–27 | 18 (12–24) |
Spirometry | 54 (41.5) | 4–43 | 18 (12–32) | 34 (54.0) | 3–33 | 21 (13–30) |
Complete blood count and serum creatinine | 49 (37.7) | 6–40 | 20 (14–30) | 27 (42.9) | 3–31 | 19 (16–28) |
Liver function tests | 27 (20.8) | 10–39 | 29 (22–30) | 14 (22.2) | 4–30 | 28 (24–29) |
Abdominal echography | 26 (20.0) | 13–36 | 27 (20–28) | 15 (23.8) | 13–28 | 26 (21–27) |